Type
Closure
Country
Croatia
Region
Hrvatska; Kontinentalna Hrvatska; Grad Zagreb
Location of affected unit(s)
Zagreb
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture Of Pharmaceutical Preparations

125 - 130 jobs
Number of planned job losses
Job loss
Announcement Date
27 April 2024
Employment effect (start)
27 April 2024
Foreseen end date
31 May 2024

Description

Israeli pharmaceutics company Teva, the owner of Croatian Pliva, has decided to sell its company TAPI. Because of this, TAPI has announced plans to shut down the company on 01 May 2024 and make 130 employees redundant.

Some of the experts will be employed in the new Pliva Centre of Excellence for Research and Development of Small Molecules, while others will obtain relatively high severance payments. The new Centre of Excellence will support Teva's business in the area of research into innovative molecules and the development of new forms of existing molecules. The intention is to strengthen Teva's future portfolio of innovative drugs and maintain Teva's position as a powerful company.

TAPI research and development, which deals with active pharmaceutical ingredients globally is located in Zagreb.


Sources

Citation

Eurofound (2024), Pliva - TAPI , Closure in Croatia, factsheet number 201146, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/201146.